Comirnaty (Pfizer-BioNTech COVID-19 Vaccine)

(COVID-19 Vaccine, mRNA)

Comirnaty (Pfizer-BioNTech COVID-19 Vaccine)

Drug updated on 11/14/2023

Dosage FormInjection (intramuscular; 0.3mL)
Drug ClassVaccines
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • Indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.